Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | gamma-aminobutyric acid (GABA) A receptor, beta 3 | Starlite/ChEMBL | References |
Homo sapiens | gamma-aminobutyric acid (GABA) A receptor, gamma 2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_129441 | All targets in OG5_129441 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_129441 | All targets in OG5_129441 |
Brugia malayi | gamma-aminobutyric-acid receptor beta subunit precursor | Get druggable targets OG5_129441 | All targets in OG5_129441 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_131775 | All targets in OG5_131775 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Neurotransmitter-gated ion-channel ligand binding domain containing protein | gamma-aminobutyric acid (GABA) A receptor, gamma 2 | 467 aa | 449 aa | 27.6 % |
Brugia malayi | excitatory GABA receptor EXP-1A | gamma-aminobutyric acid (GABA) A receptor, beta 3 | 473 aa | 441 aa | 29.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | sterol 24-c-methyltransferase, putative | 0.0187 | 0.2924 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0185 | 0.2859 | 0.5 |
Trypanosoma brucei | Sterol methyltransferase, putative | 0.0187 | 0.2924 | 1 |
Echinococcus multilocularis | geminin | 0.0185 | 0.2859 | 0.5 |
Trypanosoma cruzi | sterol 24-c-methyltransferase, putative | 0.0187 | 0.2924 | 0.5 |
Leishmania major | sterol 24-c-methyltransferase, putative | 0.0187 | 0.2924 | 0.5 |
Brugia malayi | gamma-aminobutyric-acid receptor beta subunit precursor | 0.0244 | 0.4678 | 1 |
Trypanosoma brucei | sterol 24-c-methyltransferase, putative | 0.0187 | 0.2924 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0185 | 0.2859 | 0.5 |
Trypanosoma brucei | sterol 24-c-methyltransferase, putative | 0.0187 | 0.2924 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0222 | 0.4 | 0.4 |
Loa Loa (eye worm) | hypothetical protein | 0.0244 | 0.4678 | 0.4678 |
Trypanosoma cruzi | sterol 24-c-methyltransferase, putative | 0.0187 | 0.2924 | 0.5 |
Echinococcus granulosus | geminin | 0.0185 | 0.2859 | 0.5 |
Leishmania major | sterol 24-c-methyltransferase, putative | 0.0187 | 0.2924 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Efficacy (functional) | = -0.55 % | Efficacy against recombinant human GABA-Aalpha1 receptor plus beta3gamma2 as measured by modulation of chloride ion flux | ChEMBL. | 16406613 |
Efficacy (functional) | = -0.55 % | Efficacy against recombinant human GABA-Aalpha1 receptor plus beta3gamma2 as measured by modulation of chloride ion flux | ChEMBL. | 16406613 |
Efficacy (functional) | = -0.39 % | Efficacy against recombinant human GABA-Aalpha3 receptor plus beta3gamma2 as measured by modulation of chloride ion flux | ChEMBL. | 16406613 |
Efficacy (functional) | = -0.39 % | Efficacy against recombinant human GABA-Aalpha3 receptor plus beta3gamma2 as measured by modulation of chloride ion flux | ChEMBL. | 16406613 |
Ki (binding) | = 18 nM | Displacement of [3H]Ro 15-1788 from recombinant human GABA-Aalpha1 receptor plus beta3gamma2 expressed in L(tk-) cells | ChEMBL. | 16406613 |
Ki (binding) | = 18 nM | Displacement of [3H]Ro 15-1788 from recombinant human GABA-Aalpha1 receptor plus beta3gamma2 expressed in L(tk-) cells | ChEMBL. | 16406613 |
Ki (binding) | > 33 nM | Displacement of [3H]Ro 15-1788 from recombinant human GABA-Aalpha3 receptor plus beta3gamma2 expressed in L(tk-) cells | ChEMBL. | 16406613 |
Ki (binding) | > 33 nM | Displacement of [3H]Ro 15-1788 from recombinant human GABA-Aalpha3 receptor plus beta3gamma2 expressed in L(tk-) cells | ChEMBL. | 16406613 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.